Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07380555
The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients
A Multicenter, Cluster-randomized, Controlled Study Evaluating the Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients
Sponsor: Shanghai Zhongshan Hospital
Interventions
artificial intelligence (AI) decision support system
Updated 1 time since 2026 Last updated: Jan 24, 2026 Started: Jan 30, 2026 Primary completion: Dec 31, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Heart Failure With Reduced Ejection Fraction (HF-rEF) and is currently actively recruiting participants. Shanghai Zhongshan Hospital leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai Zhongshan Hospital
Data source: Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .